39 4. COMMENTS FROM INTERESTED PARTIES, Decision_act (EU) 2015/1300

In forcesince 27 Mar 2015

As stated above, in addition to the submissions by the complainant and the BPI, the Commission received comments by 9 pharmaceutical companies. All these companies are either beneficiaries under the scheme or had unsuccessfully applied for an exemption. Due to partly overlapping arguments, the submissions by these 9 interested parties are summarised together below.